S

Shandong Weigao Blood Purification Products Co Ltd
SSE:603014

Watchlist Manager
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Watchlist
Price: 41.6 CNY 0.1% Market Closed
Market Cap: 17.4B CNY

Net Margin
Shandong Weigao Blood Purification Products Co Ltd

12.5%
Current
11%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.5%
=
Net Income
449.4m
/
Revenue
3.6B

Net Margin Across Competitors

No Stocks Found

Shandong Weigao Blood Purification Products Co Ltd
Glance View

Market Cap
17.4B CNY
Industry
Health Care

Shandong Weigao Blood Purification Products Co Ltd is a China-based company mainly engaged in the research and development, production, and sales of blood purification medical products. The Company's products mainly include hemodialysis products and peritoneal dialysis products. The hemodialysis products mainly include hemodialysis machines, hemodialysis tubing, and hemodialysis machines. The peritoneal dialysis products mainly include peritoneal dialysis fluid, and others. The Company's products are exported to multiple countries and regions such as Ecuador and Indonesia.

Intrinsic Value
35.53 CNY
Overvaluation 15%
Intrinsic Value
Price
S
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.5%
=
Net Income
449.4m
/
Revenue
3.6B
What is the Net Margin of Shandong Weigao Blood Purification Products Co Ltd?

Based on Shandong Weigao Blood Purification Products Co Ltd's most recent financial statements, the company has Net Margin of 12.5%.

Back to Top